This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Versantvoort, C. H. M. Articles by Lankelma, J. Search for Related Content PubMed PubMed Citation Articles by Versantvoort, C. H. M. Articles by Lankelma, J.

Energy-dependent Processes Involved in Reduced Drug Accumulation in Multidrug-resistant Human Lung Cancer Cell Lines without P-Glycoprotein Expression¹

Department of Medical Oncology, Free University Hospital, de Boelelaan 1117, 1081 HV Amsterdam [C. H. M. V., H. J. B., H. M. P., N. F., C. M. K., J. L.], and Department of Medical Oncology, State University of Groningen, Groningen [E. G. E. d. V.], The Netherlands

Mechanisms contributing to reduced cytotoxic drug accumulation were studied in two multidrug-resistant (MDR) human lung cancer cell lines without P-glycoprotein expression. In these (non-small cell) SW-1573/2R120 and (small cell) GLC4/ADR MDR cells, the steady-state accumulation of [¹⁴C]daunorubicin was 30 and 12%, respectively, of that in the parent cells. When cells, at steady state, were permeabilized with digitonin, the amount of daunorubicin binding increased only in the resistant cells. The reduced accumulation of daunorubicin in the SW-1573/2R120 and GLC4/ADR cells was accompanied by a lower initial (2 min) uptake rate of this drug. No difference in initial efflux rate of daunorubicin from preloaded cells could be detected between sensitive and resistant SW-1573 cells. However, daunorubicin was extruded 5-fold faster from GLC4/ADR cells than from the parental cells. In the presence of the energy metabolism inhibitors sodium azide and deoxyglucose, the reduced daunorubicin accumulations in the SW-1573/2R120 and GLC4/ADR MDR cells were (almost) completely reversed. The effects of these inhibitors on drug uptake were already apparent during the earliest measured time points (<15 s). Also, the enhanced efflux of daunorubicin from GLC4/ADR cells was inhibited. In ATP-depleted cells, the intracellular pH was lowered by 0.3 units in resistant as well as in sensitive cells. The lower intracellular pH, however, could not account for the increase in daunorubicin accumulation in the resistant cells. Also, for vincristine and etoposide, the increases in drug accumulation under energy-deprived conditions were more pronounced in the resistant SW-1573/2R120 cells than in the parent SW-1573 cells. These results suggest that accumulation of drugs in the non-P-glycoprotein MDR human lung carcinoma cell lines SW-1573/2R120 and GLC4/ADR is reduced by an energy-dependent drug export mechanism which prevents efficient transport of drug to the target. Since P-glycoprotein expression in lung tumors is generally low, these MDR lung cancer cell lines can be used as a model to study alternative mechanisms leading to multidrug resistance in this tumor type.

¹ Supported by the Netherlands Cancer Foundation (grant IKA 89-11). H. J. B. is a fellow of the Royal Netherlands Academy of Arts and Sciences.

² To whom requests for reprints should be addressed, at Department of Medical Oncology, Free University Hospital, BR 232, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Received 7/ 3/91. Accepted 10/17/91.

This article has been cited by other articles:

				A. van Zon, M. H. Mossink, M. Schoester, R. J. Scheper, P. Sonneveld, and E. A. C. Wiemer Efflux Kinetics and Intracellular Distribution of Daunorubicin Are Not Affected by Major Vault Protein/Lung Resistance-Related Protein (Vault) Expression Cancer Res., July 15, 2004; 64(14): 4887 - 4892. [Abstract] [Full Text] [PDF]

				M. Maliepaard, M. A. van Gastelen, L. A. de Jong, D. Pluim, R. C. A. M. van Waardenburg, M. C. Ruevekamp-Helmers, B. G. J. Floot, and J. H. M. Schellens Overexpression of the BCRP/MXR/ABCP Gene in a Topotecan-selected Ovarian Tumor Cell Line Cancer Res., September 1, 1999; 59(18): 4559 - 4563. [Abstract] [Full Text] [PDF]

				J. H. Hooijberg, H. J. Broxterman, M. Kool, Y. G. Assaraf, G. J. Peters, P. Noordhuis, R. J. Scheper, P. Borst, H. M. Pinedo, and G. Jansen Antifolate Resistance Mediated by the Multidrug Resistance Proteins MRP1 and MRP2 Cancer Res., June 1, 1999; 59(11): 2532 - 2535. [Abstract] [Full Text] [PDF]

				M. Sorensen, M. Sehested, and P. B. Jensen Effect of Cellular ATP Depletion on Topoisomerase II Poisons. Abrogation of Cleavable-Complex Formation by Etoposide But Not by Amsacrine Mol. Pharmacol., March 1, 1999; 55(3): 424 - 431. [Abstract] [Full Text]

				Z. Zhan, V. A. Sandor, E. Gamelin, J. Regis, B. Dickstein, W. Wilson, A. T. Fojo, and S. E. Bates Expression of the Multidrug Resistance-Associated Protein Gene in Refractory Lymphoma: Quantitation by a Validated Polymerase Chain Reaction Assay Blood, May 15, 1997; 89(10): 3795 - 3800. [Abstract] [Full Text] [PDF]